drugset / Trial / NCT01711918
Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis
NaSingle-groupOpen-labelTreatment
Summary
To provide oral domperidone to patients between the ages of 18 and 60 years of age, according to the investigator's judgment, a prokinetic effect is needed for the relief of severe gastroparesis. We have defined severe gastroparesis as 1) positive gastric emptying scintigraphy (more than 10% residue at 4 hours), 2) nausea, 3) early satiety, 4) abdominal pain. We will recruit patients for two years and the patients will be given domperidone for up to two years.
Timeline
- Start
- 2012-07
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Domperidone | Unknown | 10 mg | Oral |